Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

BACKGROUND: Optimization of the current dendritic cell (DC) culture protocol in order to promote the therapeutic efficacy of DC-based immunotherapy is warranted. Alternative differentiation of monocyte-derived DCs using granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Anguille, Sébastien, Smits, Evelien LJM, Cools, Nathalie, Goossens, Herman, Berneman, Zwi N, Van Tendeloo, Vigor FI
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807857/
https://www.ncbi.nlm.nih.gov/pubmed/20021667
http://dx.doi.org/10.1186/1479-5876-7-109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807857/
https://www.ncbi.nlm.nih.gov/pubmed/20021667
http://dx.doi.org/10.1186/1479-5876-7-109

Ejemplares similares